Related Experiment Video
Updated: Jun 27, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
ATM is required for rapid degradation of cyclin D1 in response to gamma-irradiation
Dong Wan Choo1, Hye Jung Baek, Noboru Motoyama
1Radiation Medicine Branch, National Cancer Center, Goyang-si, Gyeonggi-do, South Korea.
Abstract:
The cellular response to DNA damage induced by gamma-irradiation activates cell-cycle arrest to permit DNA repair and to prevent replication. Cyclin D1 is the key molecule for transition between the G1 and S phases of the cell-cycle, and amplification or overexpression of cyclin D1 plays pivotal roles in the development of several human cancers. To study the regulation of cyclin D1 in the DNA-damaged condition, we analyzed the proteolytic regulation of cyclin D1 expression upon gamma-irradiation. Upon gamma-irradiation, a rapid reduction in cyclin D1 levels was observed prior to p53 stabilization, indicating that the stability of cyclin D1 is controlled in a p53-independent manner. Further analysis revealed that irradiation facilitated ubiquitination of cyclin D1 and that a proteasome inhibitor blocked cyclin D1 degradation under the same conditions. Interestingly, after mutation of threonine residue 286 of cyclin D1, which is reported to be the GSK-3beta phosphorylation site, the mutant protein showed resistance to irradiation-induced proteolysis although inhibitors of GSK-3beta failed to prevent cyclin D1 degradation. Rather, ATM inhibition markedly prevented cyclin D1 degradation induced by gamma-irradiation. Our data indicate that communication between ATM and cyclin D1 may be required for maintenance of genomic integrity achieved by rapid arrest of the cell-cycle, and that disruption of this crosstalk may increase susceptibility to cancer.
Insights
Gamma-irradiation rapidly degrades cyclin D1 via a p53-independent pathway involving ubiquitination and proteasomes. ATM, not GSK-3beta, mediates this degradation, crucial for cell-cycle arrest and genomic integrity.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- DNA damage triggers cell-cycle arrest for repair, preventing replication.
- Cyclin D1 is critical for G1/S phase transition and implicated in cancer development.
- Understanding cyclin D1 regulation post-DNA damage is vital for cancer prevention.
Purpose of the Study:
- To investigate the proteolytic regulation of cyclin D1 expression following gamma-irradiation.
- To elucidate the role of p53, ubiquitination, proteasomes, GSK-3beta, and ATM in cyclin D1 degradation.
Main Methods:
- Analysis of cyclin D1 protein levels after gamma-irradiation.
- Assessment of cyclin D1 ubiquitination and degradation in the presence of proteasome inhibitors.
- Study of cyclin D1 mutant protein stability (T286A) and effects of GSK-3beta and ATM inhibitors.
Main Results:
- Gamma-irradiation caused rapid, p53-independent cyclin D1 reduction.
- Cyclin D1 degradation was mediated by ubiquitination and proteasomal pathways.
- ATM inhibition, but not GSK-3beta inhibition, prevented irradiation-induced cyclin D1 degradation.
- Mutation of Thr286 rendered cyclin D1 resistant to irradiation-induced proteolysis.
Conclusions:
- ATM-mediated regulation of cyclin D1 stability is essential for cell-cycle arrest and genomic integrity.
- Disruption of the ATM-cyclin D1 crosstalk may enhance cancer susceptibility.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Positive Regulator Molecules
Positive Regulator Molecules
Anaphase Promoting Complex

